MoneyWorks4Me

USFDA completes inspection at Natco Pharma’s API facility in Chennai

15 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has completed inspection at Natco Pharma’s Active Pharmaceutical Ingredient (API) facility in Chennai in the state of Tamil Nadu. The inspection was conducted from July 8 to July 12, 2019. The regulatory audit resulted in zero observations.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..